Once-weekly malaria prevention for eligible travelers.
Malaria is a mosquito-borne illness that can pose a risk on some international trips. Prescription prevention, together with mosquito-bite precautions, can help you prepare before departure.
ARAKODA (tafenoquine) is a newer once-weekly malaria prevention option for eligible adults. It requires documented normal quantitative G6PD test results before prescription. Runway can help arrange testing, or you can provide existing documented results for physician review.
Submit an online consultation, and a physician reviews your health history, travel plans, treatment request, and G6PD documentation to determine whether ARAKODA is appropriate. If prescribed, medication is shipped directly to your door before you go.
If a daily option is a better fit, explore atovaquone-proguanil (generic Malarone).